Passage Bio, Inc. (PASG) Tops Q2 EPS by 3c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea